STAT5A-overexpressed ovarian cancer patients can benefit from multiple types of treatment, including chemotherapy, radiotherapy, and immunotherapy because an essential limiting factor in tumor therapeutic efficacy is tumor cells’ ability to repair DNA damage. This evidence concerns the gene STAT5A and ovarian cancer.